不同的受体模型显示了连接体结合强度和位置的差异:用于传播脑炎病毒的计算药物查
Felicitas Finke1, Jonathan Hungerland1, Ilia A Solov'yov2,3,4
1Institute of Physics, Carl von Ossietzky Universität, Carl-von-Ossietzky-Str. 9-11, 26129, Oldenburg, Germany.
Molecular diversity
|May 13, 2024
概括
计算机辅助的查传性脑炎病毒 (TBE) 需要仔细评估受体模型. 不完整的结构显著影响药物结合的亲和力和位置,突出显示在查前需要进行结构完整性评估.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 结构生物学 结构生物学
背景情况:
- 传染性脑炎病毒 (TBE) 是一种在欧洲和亚洲迅速蔓延的神经变性疾病.
- 目前,疫苗接种是唯一的预防措施;目前还没有具体的治疗方法.
- 计算机辅助药物查为识别TBE治疗方法提供了一个潜在的途径.
研究的目的:
- 调查受体模型质量对TBE计算机辅助药物查的影响.
- 评估不完整或部分建模的受体结构如何影响药物结合预测.
主要方法:
- 用TBERNA聚合酶的三个不同的假定结构来进行药物查.
- 进行了计算机辅助的药物查,以探测潜在的药物与TBE受体结合.
- 分析了不同受体模型对药物受体结合亲和力和位置的影响.
主要成果:
- 受体模型的选择显著影响候选药物的预测结合亲和力.
- 不完整或部分建模的受体结构可以改变药物的预测结合位置.
- 候选药物可能表现出不同的疗效,这取决于所使用的特定受体模型.
结论:
- 准确和完整的受体结构对于可靠的药物查至关重要.
- 在开始对TBE进行实验或计算药物结合研究之前,必须彻底调查受体模型质量.
- 这项研究强调了结构验证在TBE药物发现管道中的重要性.
相关概念视频
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


